메뉴 건너뛰기




Volumn 4, Issue 2, 2004, Pages 139-148

Epidermal growth factor receptor inhibitors: A new prospective in the treatment of lung cancer

Author keywords

Epidermal growth factor receptor; Lung cancer; Monoclonal antibodies; Non small cell lung cancer; Tyrosine kinase inhibitors

Indexed keywords

CANERTINIB; CARBOPLATIN; CETUXIMAB; CI 1003; CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; ERLOTINIB; ETOPOSIDE; GEFITINIB; GEMCITABINE; IMC 225; LAPATINIB; MATUZUMAB; MONOCLONAL ANTIBODY; NAVELBINE; OXALIPLATIN; PACLITAXEL; PLACEBO; PROTEIN TYROSINE KINASE INHIBITOR; RALTITREXED; TOPOTECAN; TRANSFORMING GROWTH FACTOR; TRASTUZUMAB; UNCLASSIFIED DRUG;

EID: 1642442499     PISSN: 15680118     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568011043482106     Document Type: Review
Times cited : (72)

References (49)
  • 39
    • 0037295432 scopus 로고    scopus 로고
    • Cella, D. Semin. Oncol., 2003, 30 (Suppl 1), 39.
    • (2003) Semin. Oncol. , vol.30 , Issue.SUPPL. 1 , pp. 39
    • Cella, D.1
  • 44
    • 0037667420 scopus 로고    scopus 로고
    • Arteaga, C. Semin. Oncol., 2003, 30 (Suppl 7), 3.
    • (2003) Semin. Oncol. , vol.30 , Issue.SUPPL. 7 , pp. 3
    • Arteaga, C.1
  • 48


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.